X 
Financials Ratios
Home | Market Info | Company Profile | Financials Ratios
Astec Lifesciences Ltd.
BSE CODE: 533138   |   NSE CODE: ASTEC   |   ISIN CODE : INE563J01010   |   22-Nov-2024 Hrs IST
BSE NSE
Rs. 1060.65
8.5 ( 0.81% )
 
Prev Close ( Rs.)
1052.15
Open ( Rs.)
1052.20
 
High ( Rs.)
1065.40
Low ( Rs.)
1048.90
 
Volume
309
Week Avg.Volume
625
 
52 WK High-Low Range(Rs.)
BSE NSE
Rs. 1063.05
12.35 ( 1.18% )
 
Prev Close ( Rs.)
1050.70
Open ( Rs.)
1052.00
 
High ( Rs.)
1067.05
Low ( Rs.)
1050.00
 
Volume
9855
Week Avg.Volume
29602
 
52 WK High-Low Range(Rs.)
825.05
1474.4
Particulars Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020
Operational & Financial Ratios          
   Earnings Per Share (Rs)-23.96  13.02  45.83  33.03  24.26  
   CEPS(Rs)-5.44  30.21  63.39  46.16  36.13  
   DPS(Rs)0.00  1.50  1.50  1.50  1.50  
   Book NAV/Share(Rs)187.82  213.43  201.91  157.39  125.60  
   Tax Rate(%)24.06  26.77  25.80  27.04  22.53  
Margin Ratios          
   Core EBITDA Margin(%)-1.29  12.08  22.66  19.94  16.22  
   EBIT Margin(%)-7.98  8.81  19.14  16.73  14.07  
   Pre Tax Margin(%)-13.47  5.52  17.80  15.87  11.67  
   PAT Margin (%)-10.23  4.04  13.21  11.58  9.04  
   Cash Profit Margin (%)-2.32  9.38  18.27  16.18  13.46  
Performance Ratios          
   ROA(%)-4.81  2.68  11.20  10.35  9.19  
   ROE(%)-11.94  6.27  25.52  23.35  21.22  
   ROCE(%)-4.52  7.75  22.22  22.22  20.44  
   Asset Turnover(x)0.47  0.66  0.85  0.89  1.02  
   Sales/Fixed Asset(x)0.85  1.31  1.71  1.90  2.13  
   Working Capital/Sales(x)1981.30  -22.36  27.96  74.91  41.02  
Efficiency Ratios          
   Fixed Capital/Sales(x)1.18  0.76  0.58  0.52  0.47  
   Receivable days128.71  123.89  123.70  113.65  98.21  
   Inventory Days194.99  139.29  78.67  74.22  74.37  
   Payable days152.35  167.15  150.54  176.97  143.83  
Valuation Parameters          
   PER(x)0.00  106.21  38.24  30.29  16.49  
   PCE(x)-195.11  45.76  27.64  21.67  11.07  
   Price/Book(x)5.65  6.48  8.68  6.36  3.18  
   Yield(%)0.00  0.11  0.09  0.15  0.38  
   EV/Net Sales(x)5.62  4.86  5.49  3.87  1.69  
   EV/Core EBITDA(x)-8069.87  34.16  22.56  18.00  9.06  
   EV/EBIT(x)-70.30  54.87  28.52  22.95  11.91  
   EV/CE(x)2.99  4.01  4.01  3.16  2.55  
   M Cap / Sales4.55  4.31  5.08  3.53  1.50  
Growth Ratio          
   Net Sales Growth(%)-27.06  -7.15  21.93  6.25  21.19  
   Core EBITDA Growth(%)-100.36  -45.73  38.07  22.69  11.00  
   EBIT Growth(%)-165.90  -57.28  39.23  26.45  8.43  
   PAT Growth(%)-284.12  -71.59  38.84  36.28  33.03  
   EPS Growth(%)-284.08  -71.60  38.77  36.14  32.92  
Financial Stability Ratios          
   Total Debt/Equity(x)1.34  0.82  0.71  0.61  0.40  
   Current Ratio(x)1.00  0.95  1.05  1.02  1.04  
   Quick Ratio(x)0.51  0.39  0.67  0.69  0.66  
   Interest Cover(x)-1.45  2.68  14.32  19.51  5.85  
   Total Debt/Mcap(x)0.24  0.13  0.08  0.10  0.13